蔡 育賢

Medicine & Life Sciences

1. Urinary Bladder Neoplasms 100%
2. Carcinoma 48%
3. Prostatic Neoplasms 45%
4. Prostate 44%
5. Neoplasms 35%
6. Urinary Bladder 29%
7. Urinary Tract 28%
8. Survival 21%
9. Prostatic Hyperplasia 20%
10. Biopsy 18%
11. Transurethral Resection of Prostate 17%
12. rice bran saccharide 16%
13. prothymosin alpha 15%
14. Proteins 15%
15. ErbB Receptors 14%
16. Therapeutics 13%
17. Quality of Life 13%
18. Percutaneous Nephrolithotomy 12%
19. Nanoparticles 12%
20. Hypoxia 12%
21. Lower Urinary Tract Symptoms 11%
22. Doppler Ultrasonography 11%
23. Urine 10%
24. Cohort Studies 10%
25. Chitosan 10%
26. Growth 9%
27. Arsenic 9%
28. Renal Cell Carcinoma 8%
29. Castration 8%
30. Disease Progression 8%
31. nuclear matrix protein 22 8%
32. ethylene-vinyl alcohol copolymer 7%
33. Infections 7%
34. S-Phase Kinase-Associated Proteins 7%
35. Transitional Cell Carcinoma 7%
36. Tripartite Motif Proteins 7%
37. Drug Therapy 7%
38. Epirubicin 7%
39. Terazosin 7%
40. Gammaretrovirus 7%